Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. (Record no. 18494254)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02119 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515150833.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200812s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-5488 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1470-2045(08)70305-X |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Edwards, Beatrice J |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20081210 |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Oncology |
| Date of publication, distribution, etc. | Dec 2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1166-72 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adverse Drug Reaction Reporting Systems |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bone Density Conservation Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diphosphonates |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Approval |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Imidazoles |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Incidence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusions, Intravenous |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Jaw |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Osteonecrosis |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pamidronate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Precipitating Factors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Tooth Extraction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States Food and Drug Administration |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Zoledronic Acid |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gounder, Mrinal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McKoy, June M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boyd, Ian |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Farrugia, Mathew |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Migliorati, Cesar |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Marx, Robert |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ruggiero, Salvatore |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dimopoulos, Meletios |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Raisch, Dennis W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Singhal, Seema |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carson, Ken |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Obadina, Eniola |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trifilio, Steve |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | West, Dennis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mehta, Jayesh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bennett, Charles L |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Oncology |
| Related parts | vol. 9 |
| -- | no. 12 |
| -- | p. 1166-72 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1470-2045(08)70305-X">https://doi.org/10.1016/S1470-2045(08)70305-X</a> |
| Public note | Available from publisher's website |
No items available.